CRMD - NASDAQ

CorMedix Inc.

CRMD·NASDAQ

$8.23

+0.73%

HealthcareBiotechnology

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$645.66M

EPS2.2500

P/E Ratio3.66

Earnings Date08/06/2026

crmd

Net Common Stock Issuance

Last Annual Value

96.55M

3-Year CAGR

76%

5-Year CAGR

19%

10-Year CAGR

13%

Adjust for Inflation

CorMedix Inc. Competitors Analysis of Net Common Stock Issuance

CRMD · NASDAQ

Company	Net Common Stock Issuance	CAGR 3Y	CAGR 5Y	CAGR 10Y
CorMedix Inc. NASDAQ:CRMD	96.55M	20.0%	18.4%	31.5%
ProKidney Corp. NASDAQ:PROK	25.59M	N/A	-18.6%	N/A
Kura Oncology, Inc. NASDAQ:KURA	1.79M	-73.2%	-16.5%	N/A
EyePoint Pharmaceuticals, Inc. NASDAQ:EYPT	175.14M	-8.2%	-4.2%	35.5%
Savara Inc. NASDAQ:SVRA	135.44M	18.0%	2.1%	N/A
Tango Therapeutics, Inc. NASDAQ:TNGX	222.54M	40.6%	N/A	N/A
Septerna, Inc. NASDAQ:SEPN	1.69M	N/A	N/A	N/A
Arbutus Biopharma Corporation NASDAQ:ABUS	5.72M	-42.3%	-46.8%	N/A
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	32.26M	N/A	N/A	N/A
Palvella Therapeutics, Inc. NASDAQ:PVLA	763.00K	N/A	-58.1%	N/A

CorMedix Inc. Fair Value Envelope

CRMD · NASDAQ

Our analysis suggests that CRMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $8.23, this represents a potential HIDDEN relative to our calculated worth for CorMedix Inc..

HIDDEN

Intrinsic Value

Current Price: $8.23

Related Guides

Blog Categories

Continue your CRMD research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.